Dr Reddy's Labs bets big on generics for FY11

Hyderabad-based Dr Reddy's Laboratories is riding high on rising revenues from its generics business especially after Thursday's approval from the US FDA for a generic version of Sanofi-Aventis' anti allergy drug, Allegra D24.

Related Videos